- Roche (RHHBY.OB) CEO Severin Schwan has dismissed recently revived speculation about the possibility of a merger with Novartis (NVS), saying that Roche's founding families, who control 50.1% of voting shares, want the company to stay independent.
- Last month, Novartis board member Pierre Landolt said a tie-up could create a European "pharmaceutical champion," and could make sense "from an objective point of view."
- Novartis owns 33% of Roche's voting shares, which were amassed over a decade ago when Novartis previously had designs on a merger.
Roche chief squelches thoughts of Novartis merger
Oct 18 2013, 03:43 ET